Heat’s Hidden Toll: Aging Acceleration Revealed
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on […]
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on […]
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s […]
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s disease in a subgroup of participants [1]. Is...
Startup boasts pipeline of candidates targeting neuromuscular, neurodegenerative and cardio-metabolic diseases. Belgian biotech Augustine Therapeutics has raised $84.8 million in … Continue reading "Augustine Therapeutics lands $85m to advance HDAC6...
TruDiagnostic Founder Ryan Smith on personalized testing, disease risk prediction and how lifestyle choices can rewrite your health future. Longevity … Continue reading "‘Epigenetic testing puts control back into our...
Higher and more intense levels of physical activity may not benefit life span as much as previously thought, a new study in twins finds, highlighting multiple factors that play a...
Sens.ai Founder Paola Telfer on staving off cognitive decline and extending peak performance with transformative neurotechnology. ​In an era where … Continue reading "‘Very early detection of cognitive decline is...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
Research also identifies key methylation sites, along with processes and transcription factor targets linking epigenetics to health and aging. A … Continue reading "New study shows CheekAge clock is ‘significantly...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
CTA Content